nach oben

Die Dermatologie

Erschienen in:

25.01.2022 | Nävi | Leitthema

Gutartige nichtmelanozytäre Hauttumoren bei Syndromen

verfasst von: George-Sorin Tiplica, Klaus Fritz, Alexandra Irina Butacu, Loredana Ungureanu, Carmen Maria Sălăvăstru

Erschienen in: Die Dermatologie | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

Gutartige Hauttumoren kommen bei einer großen Zahl von Hautveränderungen vor. Die Diagnose wird in der Regel durch das klinische Bild und die Anamnese gestellt. Eine histopathologische Untersuchung ist nicht in jedem Fall zwingend erforderlich. Die Therapie besteht meistens in der Entfernung der Hautveränderungen durch Kryotherapie, Elektrochirurgie oder Laserabtragung. Differenzierte Phänotypisierungen einschließlich genetischer und epigenetischer Befunde liefern die Grundlage für ein neues Verständnis der pathogenetischen Mechanismen. Einige gutartige Hauttumoren können Teil von Syndromen sein, daher sollten Zusammenhänge mit nichtdermatologischen Befunden bekannt sein, die diese seltenen Erkrankungen charakterisieren. Der epidermale Nävus kann mit Gefäßmalformationen in Beziehung stehen, der Naevus sebaceus sowie der Becker-Nävus mit Defekten zerebral, okulär und am Skelett, Pilomatrixome können kolorektalen Karzinomen beim Gardner-Syndrom vorangehen, tuberöse Sklerose kann assoziiert sein nicht nur mit Veränderungen im Zentralnervensystem, sondern auch an Lunge, Herz oder Nieren.

Happle R (2020) Mosaicism and epidermal nevi. Braun-Falco’s dermatology, S 1–22

Thomas VD, Snavely NR, Lee KK, Swanson NA (2012) Benign epithelial tumors, hamartomas, and hyperplasias. In: Goldsmith LA, Katz S, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (Hrsg) Fitzpatrick’s dermatology in general medicine, 8. Aufl. McGraw-Hill, Medical, S 1319–1336

Poomeechaiwong S, Golitz LE (1990) Hamartomas. Adv Dermatol 5:257–287PubMed

Tjarks BJ, Gardner JM, Riddle ND (2019) Hamartomas of skin and soft tissue. Semin Diagn Pathol 36(1):48–61PubMed

Happle R (2020) The group of epidermal nevus syndromes. Part 1. Well defined phenotypes. J Am Acad Dermatol 63(1):1–22

Cohen MM Jr. (2005) Proteus syndrome: an update. Am J Med Genet C Semin Med Genet 137:38–52

Cohen MM Jr. (2014) Proteus syndrome review: molecular, clinical and pathological features. Clin Genet 85:111–119PubMed

Pilarski R (2009) Cowden syndrome: a critical review of the clinical literature. J Genet Couns 18(1):13–27PubMed

Bessis D, Plaisancie J, Gaston V, Bieth E (2017) Fibroblast growth factor receptor 3 epidermal naevus syndrome with urothelial mosaicism for the activating p.Ser249Cys FGFR3 mutation. Acta Derm Venereol 10:402–403

10.

Desai SD, Vora R, Bharani S (2014) Garcia-Hafner-Happle syndrome: a case report and review of a rare sub-type of epidermal nevus syndrome. J Pediatr Neurosci 9(1):66PubMedPubMedCentral

11.

Bergqvist C, Abdallah B, Hasbani DJ, Abbas O, Kibbi AG et al (2018) CHILD syndrome: a modified pathogenesis-targeted therapeutic approach. Am J Med Genet A 176:733–738PubMed

12.

Lai-Cheong JE, Elias PM, Paller AS (2013) Pathogenesis-based therapies in ichthyoses. Dermatol Ther 26(1):46–54PubMedPubMedCentral

13.

Wang SM, Hsieh YJ, Chang KM, Tsai HL, Chen CP (2014) Schimmelpenning syndrome: a case report and literature review. Pediatr Neonatol 55:487–490PubMed

14.

Asch S, Sugarman JL (2018) Epidermal nevus syndromes: new insights into whorls and swirls. Pediatr Dermatol 35(1):21–29PubMed

15.

Asch S, Sugarman JL (2015) Epidermal nevus syndromes. Handb Clin Neurol 132:291–316PubMed

16.

Happle R (2009) Speckled lentiginous naevus: which of the two disorders do you mean? Clin Exp Dermatol 34:133–135PubMed

17.

John AM, Schwartz RA (2016) Muir-Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol 74(3):558–566PubMed

18.

Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76(1):1–8PubMedPubMedCentral

19.

Ponti G, Ponz de Leon M (2005) Muir-Torre syndrome. Lancet Oncol 6(12):980–987PubMed

20.

Le S, Ansari U, Mumtaz A, Malik K, Patel P, Doyle A, Khachemoune A (2017) Lynch syndrome and Muir-Torre syndrome: an update and review on the genetics, epidemiology, and management of two related disorders. Dermatol Online J 23(11):13030/qt8sg5w98jPubMed

21.

Goudie D (2020) Multiple self-healing squamous epihelioma (MSSE): a digenic trait associated with loss of function in TGFBR1 and variants at a second linked locus on the long arm of chromosome 9. Genes 11:1410. https://doi.org/10.3390/genes11121410CrossRefPubMedCentral

22.

Ferguson-Smith MA, Goudie DR (2014) Diogenic/multilocus aetiology of multiple self-healing epithelioma (Ferguson-Smith disease): TGFBR1 and a second linked locus. Int J Biochem Cell Biol 53:520–525PubMed

23.

Pham F, Buiret G, Bonnet-Dupeyron MN, Beschet I, Skowron F (2021) Multiple aggressive keratoacanthomas associated with Ferguson-Smith syndrome, successfully treated by cetuximab and cisplatin. Eur J Dermatol 2:271–272

24.

Nofal A, Assaf M, Nofal E, Alradi M (2014) Generalized eruptive keratoacanthoma: proposed diagnostic criteria and therapeutic evaluation. J Eur Acad Dermatol Venereol 28:397–404PubMed

25.

Mascitti H, De Masson A, Brunet Possenti F, Bouaziz JD, Laly P et al (2019) Successful treatment of generalized eruptive keratoacanthomas of Grzybowski with acitretin. Dermatol Ther 9:383–388

26.

Sami N, Bussian A (2015) Acitretin induces remission in generalized eruptive keratoacanthoma of Grzybowsky. Int J Dermatol 54:e56–e69

27.

Street ML, White JW Jr, Gibson LE (1990) Multiple keratoacanthomas treated with oral retinoids. J Am Acad Dermatol 23:862–866PubMed

28.

Torchia D (2021) Nevus comedonicus syndrome: a systematic review of the literature. Pediatr Dermatol 38:359–363PubMed

29.

Torchia D (2021) Becker nevus syndrome: a 2020 update. J Am Acad Dermatol 85:e101–e103PubMed

30.

Patel P, Malik K, Klachemoune A (2015) Sebaceous and Becker’s nevus: overview of their presentation, pathogenesis, associations, and treatment. Am J Clin Dermatol 16:197–204PubMed

31.

Del Carmen Boente M, Asial R, Primc NB, Happle R (2013) Angora hair nevus. A further case of an unusual epidermal nevus representing a hallmark of angora hair nevus syndrome. J Dermatol Case Rep 7(2):49

32.

Kazakov DV (2016) Brooke-Spiegler syndrome and phenotypic variants: an update. Head Neck Pathol 10(2):125–130PubMedPubMedCentral

33.

Szepietowski JC, Wasik F, Szybejko-Machaj G, Bieniek A, Schwartz RA (2001) Brooke–Spiegler syndrome. J Eur Acad Dermatol Venereol 15(4):346–349PubMed

34.

Nonaka D, Rosai J, Spagnolo D et al (2004) Cylindroma of the breast of skin adnexal type: a study of 4 cases. Am J Surg Pathol 28:1070–1075PubMed

35.

Yakubov E, Ghoochani A, Buslei R, Buchfelder M, Eyupoglu IY, Savaskan N (2016) Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency. Oncoscience 3:149–155PubMedPubMedCentral

36.

Lopes S, Vide J, Moreira E, Azevedo F (2017) Cowden syndrome: clinical case and a brief review. Dermatol Online J 23(8):13030/qt0023k3x0PubMed

37.

Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E (2013) Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. JNCI J Natl Cancer Inst 105:1607–1616PubMed

38.

Gammon A, Jasperson K, Champine M (2016) Genetic basis of Cowden syndrome and its implications for clinical practice and risk management. Appl Clin Genet 9:83–92PubMedPubMedCentral

39.

Geh JL, Moss AL (1999) Multiple pilomatrixomata and myotonic dystrophy: a familial association. Br J Plast Surg 52(2):143–145PubMed

40.

Sherrod QJ, Chiu MW, Gutierrez MA (2008) Multiple pilomatricomas: cutaneous marker for myotonic dystrophy. Dermatol Online J 14(7):22PubMed

41.

Cantwell AR, Reed WB (1965) Myotonia atrophica and multiple calcifying epithelioma of Malherbe. Acta Derm Venereol 45:387–390PubMed

42.

Antohi C, Haba D, Caba L, Ciofu ML, Drug VL, Bărboi OB, Dobrovăt BI, Pânzaru MC, Gorduza NC, Lupu VV, Dimofte D, Gug C, Gorduza EV (2021) Novel mutation in APC gene associated with multiple osteomas in a family and review of genotype-phenotype correlations of extracolonic manifestations in Gardner syndrome. Diagnostics (Basel) 11(9):1560. https://doi.org/10.3390/diagnostics11091560CrossRef

43.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424PubMed

44.

Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, Bacher J, Bigley C, Nelsen L, Goodfellow PJ et al (2017) Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol 3:464–471PubMedPubMedCentral

45.

Bisgaard ML, Bülow S (2006) Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A 140(3):200PubMed

46.

Pulvermacker B, Seroussi D, Haddad R, Mitrofanoff M (2006) Pilomatricoma or calcifying epithelioma of Malherbe. A pediatric review of 89 cases. Ann Chir Plast Esthet 52(1):39–42PubMed

47.

Handler MZ, Derrick KM, Lutz RE, Morrell DS, Davenport ML, Armstrong AW (2013) Prevalence of pilomatricoma in Turner syndrome: findings from a multicenter study. JAMA Dermatol 149(5):559PubMed

48.

Ciriacks K, Knabel D, Waite MB (2020) Syndromes associated with multiple pilomatricomas: when should clinicians be concerned? Pediatr Dermatol 37(1):9–17. https://doi.org/10.1111/pde.139479–17PubMed

49.

Bondy CA, Turner Syndrome Study Group (2007) Care of girls and women with Turner syndrome: a guideline of the Turner syndrome study group. J Clin Endocrinol Metab 92(1):10PubMed

50.

Wooldridge J, Zunich J (1995) Trisomy 9 syndrome: report of a case with Crohn disease and review of the literature. Am J Med Genet 56(3):258PubMed

51.

Blaya B, Gonzalez-Hermosa R, Gardeazabal J et al (2009) Multiple pilomatricomas in association with trisomy 9. Pediatr Dermatol 26:482–484PubMed

52.

Wessels MW, Brooks AS, Hoogeboom J, Niermeijer MF, Willems PJ (2002) Kabuki syndrome: a review study of three hundred patients. Clin Dysmorphol 11(2):95–102PubMed

53.

Jones CD, Ho W, Robertson BF, Gunn E, Morley S (2018) Pilomatrixoma: a comprehensive review of the literature. Am J Dermatopathol 40(9):631–641PubMed

54.

Bueno AL, de Souza ME, Graziadio C, Kiszewski AE (2020) Multiple pilomatricomas in twins with Rubinstein-Taybi syndrome. An Bras Dermatol 95:619–622PubMedPubMedCentral

55.

Pérez-Grijalba V, García-Oguiza A, López M, Armstrong J, García-Miñaur S, Mesa-Latorre JM et al (2019) New insights into genetic variant spectrum and genotype-phenotype correlations of Rubinstein-Taybi syndrome in 39 CREBBP-positive patients. Mol Genet Genomic Med 7(11):e972. https://doi.org/10.1002/mgg3.972CrossRefPubMedPubMedCentral

56.

Papathemeli D, Schulzendorff N, Kohlhase J, Göppner D, Franke I, Gollnick H (2015) Pilomatricomas in Rubinstein-Taybi syndrome. J Dtsch Dermatol Ges 13(3):240–242. https://doi.org/10.1111/ddg.12504CrossRefPubMed

57.

Rokunohe D, Nakano H, Akasaka E, Toyomaki Y, Sawamura D (2016) Rubinstein-Taybi syndrome with multiple pilomatricomas: the first case diagnosed by CREBBP mutation analysis. J Dermatol Sci 83:240–242PubMed

58.

Hollmig ST, Tollefson MM, Kim J, Khuu P (2013) Multiple eruptive pilomatricomas in a 9-year-old boy with glioblastoma. Pediatr Dermatol 30(6):756–758PubMed

59.

Epstein CJ (2001) Down syndrome (Trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D (Hrsg) The metabolic and molecular bases of inherited disease, 8. Aufl. McGraw-Hill, New York, S 1223

60.

Maroon M, Tyler W, Marks VJ (1990) Calcinosis cutis associated with syringomas: a transepidermal elimination disorder in a patient with Down syndrome. J Am Acad Dermatol 23(2):372–375PubMed

61.

Patrizi A, Neri I, Marzaduri S, Varotti E, Passarini B (1998) Syringoma: a review of twenty-nine cases. Acta Derm Venereol 78:460–462PubMed

62.

Schwartz RA, Fernández G, Kotulska K, Jóźwiak S (2007) Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 57(2):189PubMed

63.

Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372(9639):657PubMed

64.

Bongiorno MA, Nathan N, Oyerinde O, Wang JA, Lee CC, Brown GT, Moss J, Darling TN (2017) Clinical characteristics of connective tissue nevi in tuberous sclerosis complex with special emphasis on shagreen patches. JAMA Dermatol 153(7):660–665PubMedPubMedCentral

65.

Webb DW, Clarke A, Fryer A, Osborne JP (1996) The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol 135(1):1PubMed

66.

Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63(8):1457PubMed

67.

Rowley SA, O’Callaghan FJ, Osborne JP (2001) Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol 85(4):420PubMedPubMedCentral

68.

Hinton RB, Prakash A, Romp RL, Krueger DA, Knilans TK (2014) Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the international tuberous sclerosis consensus group. J Am Heart Assoc 3(6):e1493PubMedPubMedCentral

69.

Teng JM, Cowen EW, Wataya-Kaneda M, Gosnell ES, Witman PM, Hebert AA, Mlynarczyk G, Soltani K, Darling TN (2014) Dermatologic and dental aspects of the 2012 international tuberous sclerosis complex consensus statements. JAMA Dermatol 150(10):1095PubMed

70.

Weiss ET, Geronemus RG (2010) New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis. Lasers Surg Med 42(5):357–360PubMed

71.

Sadowski K, Kotulska K, Schwartz RA, Jóźwiak S (2016) Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review. J Eur Acad Dermatol Venereol 30(4):586–594PubMed

72.

Pope V, Dupuis L, Kannu P, Mendoza-Londono R, Sajic D, So J, Yoon G, Lara-Corrales I (2016) Buschke-Ollendorff syndrome: a novel case series and systematic review. Br J Dermatol 174(4):723PubMed

73.

Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk PC, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen SJ, Savarirayan R, Van Hul W, Vanhoenacker F, Huylebroeck D, De Paepe A, Naeyaert JM, Vandesompele J, Speleman F, Verschueren K, Coucke PJ, Mortier GR (2004) Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet 36(11):1213–1218PubMed

74.

McCuaig CC, Vera C, Kokta V, Marcoux D, Hatami A, Thuraisingam T, Marton D, Fortier-Riberdy G, Powell J (2012) Connective tissue nevi in children: institutional experience and review. J Am Acad Dermatol 67(5):890–897PubMed

75.

Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, Melmed S, Sakurai A, Tonelli F, Brandi ML, Endocrine Society (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97(9):2990PubMed

76.

van Leeuwaarde RS, Dreijerink KM, Ausems MG, Beijers HJ, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Peeters PHM, Pijnappel RM, Vriens MR, Valk GD (2017) MEN1-dependent breast cancer: indication for early screening? Results from the Dutch MEN1 study group. J Clin Endocrinol Metab 102(6):2083PubMed

77.

Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Dis Primers 3:17004PubMed

78.

Young H, Hyman S, North K (2002) Neurofibromatosis 1: clinical review and exceptions to the rules. J Child Neurol 17(8):613–621PubMed

79.

Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KE (2021) Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020. JAMA Netw Open 4(3):e210945PubMedPubMedCentral

80.

Zvulunov A, Barak Y, Metzker A (1995) Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia: world statistical analysis. Arch Dermatol 131(8):904–908PubMed

81.

Ortonne N, Wolkenstein P, Blakeley JO, Korf B, Plotkin SR, Riccardi VM, Miller DC, Huson S, Peltonen J, Rosenberg A, Carroll SL, Verma SK, Mautner V, Upadhyaya M, Stemmer-Rachamimov A (2018) Cutaneous neurofibromas: current clinical and pathologic issues. Neurology 91(2):S5PubMed

82.

Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF (2012) Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS ONE 7(4):e35711PubMedPubMedCentral

83.

Ruggieri M, Huson SM (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56(11):1433PubMed

84.

Bhatia S, Chen Y, Wong FL, Hageman L, Smith K, Korf B, Cannon A, Leidy DJ, Paz A, Andress JE, Friedman GK, Metrock K, Neglia JP, Arnold M, Turcotte LM, De Blank P, Leisenring W, Armstrong GT, Robison LL, Clapp DW, Shannon K, Nakamura JL, Fisher MJ (2019) Subsequent neoplasms after a primary tumor in individuals with neurofibromatosis type 1. J Clin Oncol 37(32):3050PubMedPubMedCentral

85.

Supsrisunjai C, Hsu CK, Michael M, Duval C, Lee JY, Yang HS, Huang HY, Chaikul T, Onoufriadis A, Steiner RA, Ariëns RA (2020) Coagulation factor XIII‑A subunit missense mutation in the pathobiology of autosomal dominant multiple dermatofibromas. J Invest Dermatol 140(3):624–635PubMed

86.

Mashiah J, Hadj-Rabia S, Dompmartin A, Harroche A, Laloum-Grynberg E, Wolter M, Amoric JC, Hamel-Teillac D, Guero S, Fraitag S, Bodemer C (2014) Infantile myofibromatosis: a series of 28 cases. J Am Acad Dermatol 71(2):264–270PubMed

87.

Marsh DJ, Dahia PL, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16(4):333PubMed

88.

Roszkowski M, Dabrowski D (1997) Encephalo-cranio-cutaneous lipomatosis (ECCL)—Haberland syndrome. A case report with review of the literature. Neurol Neurochir Pol 31(3):607–613PubMed

89.

Moog U (2009) Encephalocraniocutaneous lipomatosis. J Med Genet 46(11):721–729PubMed

90.

Happle R, Küster W (1998) Nevus psiloliparus: a distinct fatty tissue nevus. Dermatology 197(1):6–10PubMed

91.

Ross CM (1969) Generalized folded skin with an underlying lipomatous nevus: the Michelin tire baby. Arch Dermatol 100(3):320–323PubMed

92.

Ulucan H, Koparir E, Koparir A, Karaca E, Emre R, Gezdirici A, Yosunkaya E, Seven M, Ozen M, Yuksel A (2013) Circumferential skin folds and multiple anomalies: confirmation of a distinct autosomal recessive Michelin tire baby syndrome. Clin Dysmorphol 22(2):87–90PubMed

93.

Kondoh T, Eguchi J, Hamasaki Y, Doi T, Kinoshita E, Matsumoto T, Abe K, Ohtani Y, Moriuchi H (2004) Hearing impairment, undescended testis, circumferential skin creases, and mental handicap (HITCH) syndrome: a case report. Am J Med Genet A 125(3):290–292

94.

Palit A, Inamadar AC (2007) Circumferential skin folds in a child: a case of Michelin tire baby syndrome. Indian J Dermatol Venereol Leprol 73(1):49PubMed

95.

Schmidt LS, Linehan WM (2014) Hereditary leiomyomatosis and renal cell carcinoma. Int J Nephrol Renovasc Dis 7:253–260PubMedPubMedCentral

96.

Alam NA, Barclay E, Rowan AJ, Tyrer JP, Calonje E, Manek S, Kelsell D, Leigh I, Olpin S, Tomlinson IP (2005) Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome. Arch Dermatol 141(2):199–206PubMed

97.

Germain DP (2017) Pseudoxanthoma elasticum. Orphanet J Rare Dis 12(1):1–3

98.

Luo H, Faghankhani M, Cao Y, Uitto J, Li Q (2021) Molecular genetics and modifier genes in pseudoxanthoma elasticum, a heritable multisystem ectopic mineralization disorder. J Invest Dermatol 141(5):1148PubMed

99.

Campens L, Vanakker OM, Trachet B, Segers P, Leroy BP, De Zaeytijd J, Voet D, De Paepe A, De Backer T, De Backer J (2013) Characterization of cardiovascular involvement in pseudoxanthoma elasticum families. Arterioscler Thromb Vasc Biol 33(11):2646PubMed

100.

Li D, Ryu E, Saeidian AH, Youssefian L, Oliphant E, Terry SF, Tong PL, Uitto J, Haass NK, Li Q (2021) GGCX mutations in a patient with overlapping pseudoxanthoma elasticum/cutis laxa-like phenotype. Br J Dermatol 184(6):1170–1174PubMed

101.

Malfait F, Wenstrup RJ, De Paepe A (2010) Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet Med 12(10):597–605PubMed

102.

Inamadar AC, Palit A (2004) Cutaneous signs in heritable disorders of the connective tissue. Indian J Dermatol Venereol Leprol 70(4):253–255PubMed

103.

Oshima J, Sidorova JM, Monnat RJ Jr. (2017) Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions. Ageing Res Rev 33:105PubMed

104.

Kubota Y, Takemoto M, Taniguchi T, Motegi SI, Taniguchi A, Nakagami H, Maezawa Y, Koshizaka M, Kato H, Mori S, Tsukamoto K, Kuzuya M, Yokote K (2021) Management guideline for Werner syndrome 2020. 6. Skin ulcers associated with Werner syndrome: prevention and non-surgical and surgical treatment. Geriatr Gerontol Int 21(2):153PubMed

105.

Levine MA (2012) An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opin Endocrinol Diabetes Obes 19(6):443–451PubMedPubMedCentral

106.

Jeong KH, Lew BL, Sim WY (2009) Osteoma cutis as the presenting feature of Albright hereditary osteodystrophy associated with pseudopseudohypoparathyroidism. Ann Dermatol 21(2):154–158PubMedPubMedCentral

107.

Pignolo RJ, Shore EM, Kaplan FS (2011) Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis 6:80PubMedPubMedCentral

108.

Kaplan FS, Shore EM (2000) Progressive osseous heteroplasia. J Bone Miner Res 15(11):2084–2094PubMed

109.

Eliason MJ, Leachman SA, Feng BJ, Schwartz ME, Hansen CD (2012) A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol 67(4):680PubMed

110.

Wilson NJ, O’Toole EA, Milstone LM, Hansen CD, Shepherd AA, Al-Asadi E, Schwartz ME, McLean WH, Sprecher E, Smith FJ (2014) The molecular genetic analysis of the expanding pachyonychia congenita case collection. Br J Dermatol 171(2):343PubMedPubMedCentral

111.

Kaspar RL (2005) Challenges in developing therapies for rare diseases including pachyonychia congenita. J Investig Dermatol Symp Proc 10(1):62PubMed

112.

Wallis T, Poole CD, Hoggart B (2016) Can skin disease cause neuropathic pain? A study in pachyonychia congenita. Clin Exp Dermatol 41(1):26PubMed

113.

Ofaiche J, Duchatelet S, Fraitag S, Nassif A, Nougué J, Hovnanian A (2014) Familial pachyonychia congenita with steatocystoma multiplex and multiple abscesses of the scalp due to the p.Asn92Ser mutation in keratin 17. Br J Dermatol 171(6):1565PubMed

Titel: Gutartige nichtmelanozytäre Hauttumoren bei Syndromen
verfasst von: George-Sorin Tiplica
Klaus Fritz
Alexandra Irina Butacu
Loredana Ungureanu
Carmen Maria Sălăvăstru
Publikationsdatum: 25.01.2022
Verlag: Springer Medizin
Schlagwörter: Nävi
Tuberöse Sklerose
Neurofibromatose Typ 1
Muir-Torre-Syndrom
Erschienen in: Die Dermatologie / Ausgabe 2/2022
Print ISSN: 2731-7005
Elektronische ISSN: 2731-7013
DOI: https://doi.org/10.1007/s00105-022-04947-0

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Gutartige nichtmelanozytäre Hauttumoren bei Syndromen

Zusammenfassung

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Update Dermatologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

Häufige Fehlerquellen in der Dermatohistologie

Häufigste benigne Gefäß‑, Muskel- und Fettgewebstumoren der Haut und ihre Therapie

Kinderdermatologie: Welcher gutartige Hauttumor ist das?

Häufige Behandlungsdiagnosen im dermatologischen Bereitschaftsdienst

Ulzerierter „Riesentumor“ der Kopfhaut

Gutartige Hauttumoren

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

Darf man die Behandlung eines Neonazis ablehnen?

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

Update Dermatologie